Allergan Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/22/2020)
| Balance Sheet | Total Assets | 94,699,100,000.00 | ROE | – |
| Balance Sheet | Total Equity | 58,173,600,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -433,500,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 6,805,200,000.00 | – | – |
| Cashflow | Operating Cash Flow | 7,238,700,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -16.02 | Div. Yield | – |
| Income | Net Income | -5,271,000,000.00 | P/E | – |
| Income | Shares Outstanding | 329,026,000.00 | P/B | – |
| Income | Total Revenue | 16,088,900,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company's segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth and other prescription and over-the-counter skin care products; and urologic products and the medical devices segment, which produces a range of medical devices, including breast implants for augmentation, revision and reconstructive surgery and tissue expanders; obesity intervention products, and facial aesthetics products. In December 2013, Allergan Inc completed the sale of its obesity intervention business to Apollo Endosurgery.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.allergan.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more